TCTMD

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

BARCELONA, Spain—Among all the big trials airing results at the European Society of Cardiology (ESC) Congress 2017, one tiny stent—and its performance—could have slipped through the cracks. Earlier ...
Medscape

BIOFLOW-V: Orsiro Bests Workhorse Xience at 12 Months

BARCELONA, SPAIN —The biodegradable-polymer Orsiro sirolimus-eluting stent (Biotronik) proved superior to the durable-polymer Xience everolimus-eluting stent (Abbott Vascular) for 12-month target ...
Healio

BIOFLOW V: Bioresorbable polymer DES reduces risk for TLR, target vessel MI

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with CAD who underwent PCI with an ultrathin, bioresorbable polymer sirolimus-eluting stent ...
MedPage Today

TCT: Orsiro Stent has Its Day in BIOFLOW V Trial

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- The ...
TCTMD

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Final 5-year follow-up from the BIOFLOW V trial continues to show advantages for the ultrathin-strut bioresorbable-polymer Orsiro DES (Biotronik) over the thin-strut, durable-polymer Xience (Abbott), ...
Healio

BIOFLOW-V: Bioresorbable polymer DES superior to durable polymer DES for 12-month TLF

Please provide your email address to receive an email when new articles are posted on . An ultra-thin sirolimus-eluting bioresorbable polymer drug-eluting stent was superior to a thin ...
The Business Journals

Stem cell company BioFlow considers move to Houston

A Michigan biotechnology company that specializes in stem cells is mulling a possible relocation to Houston. Officials from Ann Arbor-based BioFlow Technologies Inc. toured facilities including the ...